EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis

Naoka Umemoto, Maki Kakurai iD, Takanao Matsumoto, Kenta Mizuno, Otomi Cho, Takashi Sugita, Toshio Demitsu

Microorganisms · 22.01.2024 · 12 (1) · 224

DOI: 10.3390/microorganisms12010224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 22.01.2024. Verfasst von Naoka Umemoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, Japan. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The skin microbiome at lesion sites in patients with atopic dermatitis (AD) is characterized by dysbiosis. Although the administration of dupilumab, an IL-4Rα inhibitor, improves dysbiosis in the bacterial microbiome, information regarding the fungal microbiome remains limited. This study administered dupilumab to 30 patients with moderate-to-severe AD and analyzed changes in both fungal and bacterial skin microbiomes over a 12-week period. Malassezia restricta and M. globosa dominated the fungal microbiome, whereas non-Malassezia yeast species increased in abundance, leading to greater microbial diversity. A qPCR analysis revealed a decrease in Malassezia colonization following administration, with a higher reduction rate observed where the pretreatment degree of colonization was higher. A correlation was found between the group classified by the Eczema Area and Severity Index, the group categorized by the concentration of Thymus and activation-regulated chemokine, and the degree of skin colonization by Malassezia. Furthermore, an analysis of the bacterial microbiome also confirmed a decrease in the degree of skin colonization by the exacerbating factor Staphylococcus aureus and an increase in the microbial diversity of the bacterial microbiome. Our study is the first to show that dupilumab changes the community structure of the bacterial microbiome and affects the fungal microbiome in patients with AD.

Schlagwörter

Stichwörter der Autor:innen

MalasseziaStaphylococcus aureusatopic dermatitisdupilumabdysbiosisskin microbiome

Autor:innen und Institutionen

  • Department of Dermatology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, Japan.
  • Department of Microbiology, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose 204-8588, Japan.

ORCID-Profile: Maki Kakurai

Zitieren

APA

Umemoto, N., Kakurai, M., Matsumoto, T., Mizuno, K., Cho, O., Sugita, T., & Demitsu, T. (2024). Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis. Microorganisms, 12(1), 224. https://doi.org/10.3390/microorganisms12010224

Vancouver

Umemoto N, Kakurai M, Matsumoto T, Mizuno K, Cho O, Sugita T, et al. Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis. Microorganisms. 2024;12(1):224. doi:10.3390/microorganisms12010224

BibTeX
@article{Umemoto2024,
  author = {Umemoto, Naoka and Kakurai, Maki and Matsumoto, Takanao and Mizuno, Kenta and Cho, Otomi and Sugita, Takashi and Demitsu, Toshio},
  title = {Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {1},
  pages = {224},
  doi = {10.3390/microorganisms12010224}
}
Kostenlos starten →